Core Viewpoint - Northern Mining (00433) has completed the subscription agreement, fulfilling all conditions precedent, with the subscription completed on August 18, 2025 [1] Group 1: Subscription Details - The subscriber has acquired a total of 2.4905 billion shares at a subscription price of HKD 0.03 per share [1] - The net proceeds from the subscription, after deducting professional fees and other related expenses, amount to approximately HKD 74.7 million [1] Group 2: Use of Proceeds - The company plans to use the net proceeds to repay bank loans and other borrowings under its current liabilities, as well as for general working capital [1]

Group 1 - The company China Antibody-B (03681) announced the issuance of 157 million subscription shares to the subscribers based on the subscription agreement on August 15, 2025 [1]

Group 1 - TCL Technology Group Co., Ltd. was established on July 17, 1997, and became a joint-stock company in 2002, listed on the Shenzhen Stock Exchange in 2004 [2] - The company plans to acquire 21.5311% equity of Shenzhen Huaxing Optoelectronics Technology Co., Ltd. through issuing shares and cash payment, as approved by the China Securities Regulatory Commission [2] - The company will issue 1,035,489,574 shares at a price of RMB 4.21 per share, increasing its registered capital to RMB 20,800,862,447 [2] Group 2 - As of August 8, 2025, the company has raised a total of RMB 4,300,995,724.98 after deducting issuance costs [2] - The total issuance costs amounted to RMB 61,920,304.45, with a net amount raised after costs being RMB 4,300,995,724.98 [2] - The main underwriter for the issuance is Shenwan Hongyuan Securities Co., Ltd., and the bank has confirmed the funds transferred to the company's account [2]

Group 1 - The company, Fourth Paradigm (06682), announced that all conditions of the placement agreement have been met, and the completion of the subscription agreement is set for August 14, 2025 [1] - A total of 25.9 million subscription shares have been issued at a subscription price of HKD 50.50 per share, representing approximately 8.78% of the issued H shares before completion and about 5.25% of the total issued shares [1] - The issuance of subscription shares will increase the total number of issued H shares by approximately 8.07% and the total issued shares by about 4.98% [1]

Group 1 - North Sea Kangcheng-B signed a subscription agreement with Baiyang Health Industry International Trade Co., Ltd. to issue 74.9715 million shares at HKD 1.34 per share, representing a discount of approximately 19.76% compared to the previous trading day's closing price [2] - The subscription is expected to raise HKD 100 million, with net proceeds estimated at approximately HKD 98.6618 million, which will be used for product research and development, marketing promotion, loan repayment, and daily operations [2] - The company's shares will be suspended from trading starting at 9:00 AM on August 12, 2025, and will resume trading at 9:00 AM on August 13, 2025 [2]

Core Viewpoint - The company, 北海康成-B (01228), has entered into a subscription agreement with 百洋健康产业国际商贸有限公司 to issue 74.9715 million shares at a subscription price of HKD 1.34 per share, representing a discount of approximately 19.76% from the closing price of HKD 1.67 on August 11, 2025 [1] Group 1 - The total amount raised from the subscription will be HKD 100 million, with a net amount estimated at approximately HKD 98.6618 million after deducting related expenses [1] - The net proceeds from the subscription are intended to be used for (i) research and development of commercialized products; (ii) marketing and promotional activities; (iii) repayment of loan financing and borrowings; and (iv) general operational activities of the group [1] - Trading of the company's shares was suspended on the Hong Kong Stock Exchange from 9:00 AM on August 12, 2025, at the request of the company, pending the announcement [1]

Core Viewpoint - North Sea Kangcheng-B (01228) has entered into a subscription agreement with Baiyang Health Industry International Trade Co., Ltd. to issue 74.9715 million subscription shares at a price of HKD 1.34 per share, representing a discount of approximately 19.76% from the closing price of HKD 1.67 on August 11, 2025 [1] Group 1 - The total amount raised from the subscription will be HKD 100 million, with a net amount estimated at approximately HKD 98.6618 million after deducting related expenses [1] - The net proceeds from the subscription will be used for (i) research and development of commercialized products; (ii) marketing and promotional activities; (iii) repayment of loan financing and borrowings; and (iv) daily operations of the group [1] - Trading of the shares has been suspended on the Hong Kong Stock Exchange from 9:00 AM on August 12, 2025, at the company's request, with a resumption of trading expected on August 13, 2025 [1]

Core Viewpoint - Feidao Tourism Technology (08069) plans to issue a total of 136 million shares to ASPECT, Inc., representing approximately 16.67% of the company's expanded issued share capital after the issuance [1] Group 1: Share Issuance Details - The subscription price is set at HKD 0.0306 per share, which is a discount of about 4.38% compared to the closing price of HKD 0.032 per share on August 1 [1] - The total amount raised from the subscription is approximately HKD 4.17 million, with a net amount of about HKD 4 million [1] Group 2: Use of Proceeds - The net proceeds are intended to be used for promoting the school travel market and the tourism industry [1]

Core Viewpoint - China Ruyi (00136) has announced a subscription agreement with Infinity Capital Management Limited, involving the conditional subscription of 1.3 billion shares at a price of HKD 3.00 per share, representing approximately 7.51% of the enlarged issued share capital [1] Group 1: Subscription Agreement Details - The subscription price of HKD 3.00 per share reflects a discount of approximately 4.46% compared to the closing price of HKD 3.14 on July 31, 2025 [1] - The total net proceeds from the subscription, after deducting related fees and expenses, are expected to be approximately HKD 38.95 billion [1] Group 2: Use of Proceeds - The company plans to allocate the net proceeds as follows: 20% for business growth and expansion, 60% for strategic investments and acquisitions to enhance the group's business, and 20% for general working capital purposes, including advertising, employee costs, technology development services, and rental costs [1]

Group 1 - The company plans to issue a total of 221.5 million shares to specific subscribers, which will represent approximately 12.12% of the enlarged issued share capital after the issuance [1] - The subscription price per share is set at HKD 0.10, reflecting a premium of about 44.93% compared to the closing price of HKD 0.069 on July 29 [1] - The total amount expected to be raised from this placement is HKD 22.15 million, with a net amount of approximately HKD 22.02 million [1] Group 2 - Approximately HKD 13.2 million of the raised funds will be used to repay overdue lease payments and other payables due within three months from the announcement date [1] - About HKD 8.8 million will be allocated for the company's general working capital [1]